These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Current status of molecular biology in blood coagulation]. Yoshitake S Nihon Rinsho; 1987 Dec; 45(12):2926-33. PubMed ID: 3446881 [No Abstract] [Full Text] [Related]
5. [Recent progress of the molecular biology of human endocrinological disorders]. Goto K; Nawata H Nihon Rinsho; 1989 Oct; 47(10):2372-81. PubMed ID: 2481757 [No Abstract] [Full Text] [Related]
6. [Production of blood coagulation factors and related factors by gene technology]. Suzuki K Nihon Rinsho; 1987 Dec; 45(12):2971-82. PubMed ID: 2833649 [No Abstract] [Full Text] [Related]
7. [Screening in activated protein C resistance]. Bergmann F Internist (Berl); 1997 Sep; 38(9):864. PubMed ID: 9410836 [No Abstract] [Full Text] [Related]
8. DNA analysis as clinical investigation: when and how? Jeanpierre M; Junien C Ann Genet; 1984; 27(3):134-47. PubMed ID: 6095729 [No Abstract] [Full Text] [Related]
9. Inherited blood clotting disorders. Report of a WHO scientific group. World Health Organ Tech Rep Ser; 1972; 504():1-48. PubMed ID: 4628660 [No Abstract] [Full Text] [Related]
10. [DNA and its message in disease]. Kontula K Duodecim; 1986; 102(16):1070-6. PubMed ID: 3463503 [No Abstract] [Full Text] [Related]
12. Interstitial deletion of chromosome 1q [del(1)(q24q25.3)] identified by fluorescence in situ hybridization and gene dosage analysis of apolipoprotein A-II, coagulation factor V, and antithrombin III. Takano T; Yamanouchi Y; Mori Y; Kudo S; Nakayama T; Sugiura M; Hashira S; Abe T Am J Med Genet; 1997 Jan; 68(2):207-10. PubMed ID: 9028459 [TBL] [Abstract][Full Text] [Related]
13. [Chemical and enzymatic synthesis and the cloning of the human proinsulin gene]. Ovchinnikov IuA; Efimov VA; Chakhmakhcheva OG Dokl Akad Nauk SSSR; 1983; 270(3):743-7. PubMed ID: 6309491 [No Abstract] [Full Text] [Related]
14. [Manipulation of embryos, cells, nuclei and genes. II. Genetic engineering]. Zorzopulos J; Denoya CD Rev Argent Microbiol; 1982; 14(1):41-76. PubMed ID: 6100999 [No Abstract] [Full Text] [Related]
15. How to evaluate phenotype-genotype relationship in rare coagulation haemorrhagic disorders: examples from FVII deficiency. Bernardi F; Marchetti G; Dolce A; Mariani G Haemophilia; 2004 Oct; 10 Suppl 4():177-9. PubMed ID: 15479394 [TBL] [Abstract][Full Text] [Related]
16. Practical and ethical problems in human genetics. Hirschhorn K Birth Defects Orig Artic Ser; 1972 Jul; 8(4):17-30. PubMed ID: 4508252 [No Abstract] [Full Text] [Related]
17. The genetics of blood coagulation. Graham JB; Barrow ES; Reisner HM; Edgell CJ Adv Hum Genet; 1983; 13():1-81. PubMed ID: 6362359 [No Abstract] [Full Text] [Related]
18. Prospects for the prevention of genetic disease. Danks DM Med J Aust; 1973 Mar; 1(12):573-7. PubMed ID: 4267046 [No Abstract] [Full Text] [Related]
19. Cloning and functional expression of venom prothrombin activator protease from Pseudonaja textilis with whole blood procoagulant activity. Filippovich I; Sorokina N; St Pierre L; Flight S; de Jersey J; Perry N; Masci PP; Lavin MF Br J Haematol; 2005 Oct; 131(2):237-46. PubMed ID: 16197456 [TBL] [Abstract][Full Text] [Related]